MUSK_HUMAN - dbPTM
MUSK_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID MUSK_HUMAN
UniProt AC O15146
Protein Name Muscle, skeletal receptor tyrosine-protein kinase
Gene Name MUSK
Organism Homo sapiens (Human).
Sequence Length 869
Subcellular Localization Cell junction, synapse, postsynaptic cell membrane
Single-pass type I membrane protein . Colocalizes with acetylcholine receptors (AChR) to the postsynaptic cell membrane of the neuromuscular junction.
Protein Description Receptor tyrosine kinase which plays a central role in the formation and the maintenance of the neuromuscular junction (NMJ), the synapse between the motor neuron and the skeletal muscle. [PubMed: 25537362 Recruitment of AGRIN by LRP4 to the MUSK signaling complex induces phosphorylation and activation of MUSK, the kinase of the complex. The activation of MUSK in myotubes regulates the formation of NMJs through the regulation of different processes including the specific expression of genes in subsynaptic nuclei, the reorganization of the actin cytoskeleton and the clustering of the acetylcholine receptors (AChR) in the postsynaptic membrane. May regulate AChR phosphorylation and clustering through activation of ABL1 and Src family kinases which in turn regulate MUSK. DVL1 and PAK1 that form a ternary complex with MUSK are also important for MUSK-dependent regulation of AChR clustering. May positively regulate Rho family GTPases through FNTA. Mediates the phosphorylation of FNTA which promotes prenylation, recruitment to membranes and activation of RAC1 a regulator of the actin cytoskeleton and of gene expression. Other effectors of the MUSK signaling include DNAJA3 which functions downstream of MUSK. May also play a role within the central nervous system by mediating cholinergic responses, synaptic plasticity and memory formation (By similarity]
Protein Sequence MRELVNIPLVHILTLVAFSGTEKLPKAPVITTPLETVDALVEEVATFMCAVESYPQPEISWTRNKILIKLFDTRYSIRENGQLLTILSVEDSDDGIYCCTANNGVGGAVESCGALQVKMKPKITRPPINVKIIEGLKAVLPCTTMGNPKPSVSWIKGDSPLRENSRIAVLESGSLRIHNVQKEDAGQYRCVAKNSLGTAYSKVVKLEVEVFARILRAPESHNVTFGSFVTLHCTATGIPVPTITWIENGNAVSSGSIQESVKDRVIDSRLQLFITKPGLYTCIATNKHGEKFSTAKAAATISIAEWSKPQKDNKGYCAQYRGEVCNAVLAKDALVFLNTSYADPEEAQELLVHTAWNELKVVSPVCRPAAEALLCNHIFQECSPGVVPTPIPICREYCLAVKELFCAKEWLVMEEKTHRGLYRSEMHLLSVPECSKLPSMHWDPTACARLPHLDYNKENLKTFPPMTSSKPSVDIPNLPSSSSSSFSVSPTYSMTVIISIMSSFAIFVLLTITTLYCCRRRKQWKNKKRESAAVTLTTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSMRAQVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKANENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILSCPENCPVELYNLMRLCWSKLPADRPSFTSIHRILERMCERAEGTVSV
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
14PhosphorylationIPLVHILTLVAFSGT
CCHHHHHHHHHCCCC
20.7024043423
19PhosphorylationILTLVAFSGTEKLPK
HHHHHHCCCCCCCCC
34.7624043423
21PhosphorylationTLVAFSGTEKLPKAP
HHHHCCCCCCCCCCC
28.8424043423
31PhosphorylationLPKAPVITTPLETVD
CCCCCEECCCHHHHH
23.69-
76PhosphorylationKLFDTRYSIRENGQL
HHHCCCEEEECCCEE
16.3324719451
153PhosphorylationGNPKPSVSWIKGDSP
CCCCCCCCCCCCCCC
27.6728961369
195PhosphorylationYRCVAKNSLGTAYSK
EEEEEECCCCCCHHH
27.7225219547
198PhosphorylationVAKNSLGTAYSKVVK
EEECCCCCCHHHHEE
27.9325219547
200PhosphorylationKNSLGTAYSKVVKLE
ECCCCCCHHHHEEHH
14.6325219547
201PhosphorylationNSLGTAYSKVVKLEV
CCCCCCHHHHEEHHH
19.2625219547
222N-linked_GlycosylationLRAPESHNVTFGSFV
HCCCHHCCCCCCEEE
43.75UniProtKB CARBOHYD
275PhosphorylationSRLQLFITKPGLYTC
HCCEEEEECCCEEEE
24.6929978859
280PhosphorylationFITKPGLYTCIATNK
EEECCCEEEEEEECC
12.8929978859
281PhosphorylationITKPGLYTCIATNKH
EECCCEEEEEEECCC
11.5029978859
285PhosphorylationGLYTCIATNKHGEKF
CEEEEEEECCCCCCC
25.5329978859
293PhosphorylationNKHGEKFSTAKAAAT
CCCCCCCCCCHHHHE
38.22-
294PhosphorylationKHGEKFSTAKAAATI
CCCCCCCCCHHHHEE
35.00-
316PhosphorylationPQKDNKGYCAQYRGE
CCCCCCCCCHHHHHH
6.0429759185
320PhosphorylationNKGYCAQYRGEVCNA
CCCCCHHHHHHHHHH
11.3229759185
338N-linked_GlycosylationKDALVFLNTSYADPE
HCEEEEEECCCCCHH
18.60UniProtKB CARBOHYD
339PhosphorylationDALVFLNTSYADPEE
CEEEEEECCCCCHHH
25.8426074081
340PhosphorylationALVFLNTSYADPEEA
EEEEEECCCCCHHHH
19.7626074081
341PhosphorylationLVFLNTSYADPEEAQ
EEEEECCCCCHHHHH
17.0026074081
417PhosphorylationWLVMEEKTHRGLYRS
HHHCCCCCCCCCCCC
21.7824719451
424PhosphorylationTHRGLYRSEMHLLSV
CCCCCCCCCCEEECC
26.22-
430PhosphorylationRSEMHLLSVPECSKL
CCCCEEECCCCHHCC
41.82-
435PhosphorylationLLSVPECSKLPSMHW
EECCCCHHCCCCCCC
35.2524719451
554PhosphorylationRLHPNPMYQRMPLLL
CCCCCCHHHCCCCHH
8.3310781064
577PhosphorylationYPRNNIEYVRDIGEG
CCCCCCEEEEECCCC
9.2910781064
681PhosphorylationTVCSLSHSDLSMRAQ
CEEECCCCHHHHEEE
36.55-
698PhosphorylationSPGPPPLSCAEQLCI
CCCCCCCCHHHHHHH
19.63-
751PhosphorylationFGLSRNIYSADYYKA
HCCCCCEECCCCCCC
11.0110781064
755PhosphorylationRNIYSADYYKANEND
CCEECCCCCCCCCCC
13.4410781064
756PhosphorylationNIYSADYYKANENDA
CEECCCCCCCCCCCC
12.2710781064
813PhosphorylationMAHEEVIYYVRDGNI
CCCCEEEEEEECCCE
10.9010781064

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
681SPhosphorylationKinaseCK2-Uniprot
698SPhosphorylationKinaseCK2-Uniprot
-KUbiquitinationE3 ubiquitin ligasePDZRN3Q9UPQ7
PMID:17576800

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of MUSK_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of MUSK_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SYNE1_HUMANSYNE1physical
10878022
PZRN3_HUMANPDZRN3physical
17576800
ADA30_HUMANADAM30physical
28514442
DJC13_HUMANDNAJC13physical
28514442
RBNS5_HUMANRBSNphysical
28514442
ILKAP_HUMANILKAPphysical
28065597
STYX_HUMANSTYXphysical
28065597

Drug and Disease Associations
Kegg Disease
H00770 Congenital myasthenic syndrome
OMIM Disease
616325Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency (CMS9)
208150Fetal akinesia deformation sequence (FADS)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of MUSK_HUMAN

loading...

Related Literatures of Post-Translational Modification

TOP